Deciphera Pharmaceuticals, Inc. (DCPH) Social Stream
DECIPHERA PHARMACEUTICALS INC (DCPH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DECIPHERA PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $64 | $10 | $23.8 | $14.9 | 59.73% |
| 2021-11-30 | 10 | $64 | $10 | $19.1 | $14.9 | 28.19% |
| 2021-12-01 | 10 | $64 | $10 | $18.1 | $14.9 | 21.48% |
| 2022-02-09 | 10 | $64 | $10 | $17.4 | $14.9 | 16.78% |
| 2022-02-10 | 10 | $64 | $8 | $17.2 | $14.9 | 15.44% |
| 2022-02-28 | 10 | $64 | $6 | $16.7 | $14.9 | 12.08% |
| 2022-04-26 | 10 | $64 | $6 | $16.8 | $14.9 | 12.75% |
| 2022-05-09 | 10 | $64 | $6 | $16.6 | $14.9 | 11.41% |
| 2022-07-27 | 9 | $64 | $6 | $18.125 | $14.9 | 21.64% |
| 2022-08-02 | 9 | $64 | $6 | $17.222 | $14.9 | 15.58% |
| 2022-08-05 | 9 | $23 | $6 | $14.666 | $14.9 | -1.57% |
| 2022-08-11 | 9 | $23 | $6 | $14.777 | $14.9 | -0.83% |
| 2022-08-30 | 10 | $25 | $6 | $15.8 | $14.9 | 6.04% |
| 2022-09-12 | 10 | $25 | $6 | $17.2 | $14.9 | 15.44% |
| 2022-11-03 | 10 | $25 | $6 | $17.9 | $14.9 | 20.13% |
| 2022-11-04 | 10 | $25 | $6 | $18.65 | $14.9 | 25.17% |
| 2023-01-03 | 9 | $25 | $6 | $19.388 | $14.9 | 30.12% |
| 2023-01-04 | 10 | $28 | $9 | $20.6 | $14.9 | 38.26% |
| 2023-01-18 | 10 | $28 | $9 | $21.1 | $14.9 | 41.61% |
| 2023-01-26 | 10 | $30 | $9 | $21.6 | $14.9 | 44.97% |
| 2023-02-08 | 10 | $30 | $9 | $21.5 | $14.9 | 44.3% |
| 2023-04-25 | 9 | $30 | $9 | $21.5 | $14.9 | 44.3% |
| 2023-05-04 | 9 | $30 | $9 | $21.2 | $14.9 | 42.28% |
| 2023-07-26 | 8 | $30 | $9 | $21.333 | $14.9 | 43.17% |
| 2023-10-31 | 8 | $30 | $9 | $22 | $14.9 | 47.65% |
| 2023-11-01 | 8 | $34 | $9 | $23.777 | $14.9 | 59.58% |
| 2023-11-20 | 10 | $34 | $9 | $22.8 | $14.9 | 53.02% |
| 2023-12-15 | 10 | $34 | $9 | $23.4 | $14.9 | 57.05% |
The Trend in the Analyst Price Target
DCPH's average price target has moved up $6 over the prior 22 months.
DCPH reports an average of 58.84% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-18 | 10 | 28 | 9 | 21.100 | 20.61 | 2.38% |
| 2023-01-26 | 10 | 30 | 9 | 21.600 | 17.98 | 20.13% |
| 2023-04-24 | 9 | 30 | 9 | 21.500 | 14.32 | 50.14% |
| 2023-05-04 | 8 | 30 | 9 | 21.333 | 13.28 | 60.64% |
| 2023-10-31 | 8 | 30 | 9 | 22.000 | 11.99 | 83.49% |
DCPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 8 | 0 | 1 | 1 | 1 | 10 |
The Trend in the Broker Recommendations
DCPH's average broker recommendation rating improved by 0.73 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- DECIPHERA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2954.13% of all US stocks.
- In terms of how DECIPHERA PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 796.63% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, DECIPHERA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 890.11% of them.
- In terms of how DECIPHERA PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 2247.11% of that group.
Stocks similar to DECIPHERA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZYME, AUPH, and HCM.
View All Top Stocks by Price Target
Is DCPH a Buy, Hold or Sell? See the POWR Ratings now!